MVP Lab investigates how vascular dynamics shape disease progression, with a particular focus on vessel–immune crosstalks in the tumor microenvironment.

Leveraging microphysiological systems (organ-on-a-chip) and advanced preclinical models, we integrate multiscale analyses from the molecular to the organism level to drive breakthroughs in disease therapeutics.

Established in 2026, MVP Lab is building a multidisciplinary team of “MVPs” (Most Valuable Players) who combine scientific excellence with collaborative spirit to tackle critical unmet medical challenges.